105 related articles for article (PubMed ID: 8215255)
1. Cerebrospinal fluid inhibits Alzheimer beta-amyloid fibril formation in vitro.
Wisniewski T; Castano E; Ghiso J; Frangione B
Ann Neurol; 1993 Oct; 34(4):631-3. PubMed ID: 8215255
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer beta-amyloid peptides: structures of amyloid fibrils and alternate aggregation products.
Gorman PM; Chakrabartty A
Biopolymers; 2001; 60(5):381-94. PubMed ID: 12115148
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid of Alzheimer patients promotes beta-amyloid fibril formation in vitro.
Ono K; Noguchi M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M
Neurobiol Dis; 2005 Nov; 20(2):233-40. PubMed ID: 16242632
[TBL] [Abstract][Full Text] [Related]
4. Amyloid beta protein and the basis for Alzheimer's disease.
Glenner GG
Prog Clin Biol Res; 1989; 317():857-68. PubMed ID: 2690126
[TBL] [Abstract][Full Text] [Related]
5. Blood-borne factors inhibit Alzheimer's beta-amyloid fibril formation in vitro.
Ono K; Noguchi-Shinohara M; Samuraki M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M
Exp Neurol; 2006 Nov; 202(1):125-32. PubMed ID: 16806179
[TBL] [Abstract][Full Text] [Related]
6. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
[TBL] [Abstract][Full Text] [Related]
7. Structure of beta-amyloid fibrils and its relevance to their neurotoxicity: implications for the pathogenesis of Alzheimer's disease.
Irie K; Murakami K; Masuda Y; Morimoto A; Ohigashi H; Ohashi R; Takegoshi K; Nagao M; Shimizu T; Shirasawa T
J Biosci Bioeng; 2005 May; 99(5):437-47. PubMed ID: 16233815
[TBL] [Abstract][Full Text] [Related]
8. First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro.
Naiki H; Nakakuki K
Lab Invest; 1996 Feb; 74(2):374-83. PubMed ID: 8780157
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation.
Soto C; Kindy MS; Baumann M; Frangione B
Biochem Biophys Res Commun; 1996 Sep; 226(3):672-80. PubMed ID: 8831674
[TBL] [Abstract][Full Text] [Related]
10. A peptide hairpin inhibitor of amyloid beta-protein oligomerization and fibrillogenesis.
Yamin G; Ruchala P; Teplow DB
Biochemistry; 2009 Dec; 48(48):11329-31. PubMed ID: 19877710
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid.
Wisniewski T; Golabek A; Matsubara E; Ghiso J; Frangione B
Biochem Biophys Res Commun; 1993 Apr; 192(2):359-65. PubMed ID: 8484748
[TBL] [Abstract][Full Text] [Related]
12. Liquid chromatography/tandem mass spectrometry characterization of oxidized amyloid beta peptides as potential biomarkers of Alzheimer's disease.
Inoue K; Garner C; Ackermann BL; Oe T; Blair IA
Rapid Commun Mass Spectrom; 2006; 20(5):911-8. PubMed ID: 16470704
[TBL] [Abstract][Full Text] [Related]
13. The amyloid-beta peptide and its role in Alzheimer's disease.
Clippingdale AB; Wade JD; Barrow CJ
J Pept Sci; 2001 May; 7(5):227-49. PubMed ID: 11428545
[TBL] [Abstract][Full Text] [Related]
14. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.
Schuster D; Rajendran A; Hui SW; Nicotera T; Srikrishnan T; Kruzel ML
Neuropeptides; 2005 Aug; 39(4):419-26. PubMed ID: 15890402
[TBL] [Abstract][Full Text] [Related]
16. Interaction between synthetic amyloid-beta-peptide (1-40) and its aggregation inhibitors studied by electrospray ionization mass spectrometry.
Skribanek Z; Baláspiri L; Mák M
J Mass Spectrom; 2001 Nov; 36(11):1226-9. PubMed ID: 11747119
[TBL] [Abstract][Full Text] [Related]
17. Immunogold labeling of cerebrovascular and neuritic plaque amyloid fibrils in Alzheimer's disease with an anti-beta protein monoclonal antibody.
Ikeda S; Wong CW; Allsop D; Landon M; Kidd M; Glenner GG
Lab Invest; 1987 Oct; 57(4):446-9. PubMed ID: 3312810
[TBL] [Abstract][Full Text] [Related]
18. Phenolic oxime oligomers inhibit Alzheimer's amyloid fibril formation and disaggregate fibrils in vitro.
Dolphin GT; Renaudet O; Ouberai M; Dumy P; Garcia J; Reymond JL
Chembiochem; 2009 May; 10(8):1325-9. PubMed ID: 19415707
[TBL] [Abstract][Full Text] [Related]
19. Nicotine inhibits amyloid formation by the beta-peptide.
Salomon AR; Marcinowski KJ; Friedland RP; Zagorski MG
Biochemistry; 1996 Oct; 35(42):13568-78. PubMed ID: 8885836
[TBL] [Abstract][Full Text] [Related]
20. Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer's disease.
El-Agnaf OM; Mahil DS; Patel BP; Austen BM
Biochem Biophys Res Commun; 2000 Jul; 273(3):1003-7. PubMed ID: 10891362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
